Join an Observational Pregnancy Study
Volunteer for research to improve the health of moms and babies.
MotherToBaby is currently enrolling pregnant women in a study examining the use of Dupixent® (dupilumab) to treat moderate-to-severe eczema (atopic dermatitis) and asthma during pregnancy. The study is conducted through phone interviews—no changes to your normal routine or travel required. If you’ve taken Dupixent® (dupilumab) and are pregnant, you may qualify for this important study.
“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”
— Christina Chambers, PhD MPH, MotherToBaby Pregnancy Studies
Make an impact on maternal health by enrolling MotherToBaby is the most trusted information source for medication safety in pregnancy. Make an impact on maternal health by enrolling into our pregnancy study.
Join our Dupixent® Study
Your information is confidential.
Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at MotherToBaby.org.
Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby recognizes that not all people identify as “men” or “women.” When using the term “mother,” we mean the source of the egg and/or uterus and by “father,” we mean the source of the sperm, regardless of the person’s gender identity. Copyright by OTIS, September 19, 2018.